You are here

Laboratorios Ordesa incorporates b-2Cool®, Bioiberica’s native type II collagen, in its new Colnatur® Forte

15 Jul 2020
  • Native type II collagen is one of the most innovative ingredients in the joint health market
  • Colnatur® Forte is a food supplement especially recommended for intensive joint and bone care
  • This launch is the result of the deal signed by the two companies to offer innovative formulas in joint health

Laboratorios Ordesa has announced the launch of Colnatur® Forte, a new food supplement especially recommended for the intensive care of joints and bones. The product has an innovative formula based on b-2Cool® (Bioiberica’s native type II collagen), willow extract, devil’s claw (harpagophytum procumbens) extract, hyaluronic acid, and vitamin C.

Collagen is a fundamental articular cartilage protein, essential for it to function normally. B-2Cool® is an innovative ingredient developed by Bioiberica which supplies native type II collagen. Taking b-2Cool® orally has been shown in four scientific studies to help maintain good joint health at a very low daily dose. And it does so thanks to a mechanism called "oral tolerance" that regulates the degradation of collagen in the joints[1], making it one of the most innovative ingredients on the market.

This launch is the result of an agreement between Laboratorios Ordesa and Bioiberica to offer innovative formulas for joint health through scientifically proven ingredients.

According to Joan Permanyer, President of Laboratorios Ordesa, this agreement “means one more step in our company's commitment to R&D with the aim of offering innovative formulas to support health care at different stages of life. Joint health is becoming a more important issue due to the aging of the population and the need to prevent possible diseases and maintain an active life style at any age”.

With this partnership we are combining Bioiberica's expertise in the development, production, and marketing of natural ingredients with high added value for joint health and Ordesa's experience and leadership in offering high quality products for people’s nutrition, health, and well-being. It is without a doubt a major agreement to continue innovating together in this market’, adds Jaume Reguant, director of Bioiberica Healthcare.

Joint health is a major public health concern, largely because of an ageing population. Age can significantly affect the muscles, bones, and joints. A total of 45% of people over 65 say they experience pain and that their mobility and autonomy have been affected.

Laboratorios Ordesa has a history of more than 75 years offering the best products in infant feeding and leads the market with solutions for all stages and needs. More than two generations of Spanish babies have been fed with Blemil and Blevit infant milks and cereals, in addition to offering a wide range of food supplements that cover the entire pediatric age. Laboratorios Ordesa also has a family of products aimed at caring for adults and the elderly. It has a line dedicated to the care of women DONNAplus, the range of nutritional supplements for adults FontActiv and natural products based on collagen Colnatur.

Bioiberica is a global corporation in the life sciences industry committed to improving the health and well-being of people, animals, and plants. Bioiberica is the leading manufacturer of the active principle heparin and the world bellwether in research, production, and sale of other active pharmaceutical and nutritional ingredients like chondroitin sulphate, glucosamine, hyaluronic acid, native type II collagen, and thyroid extracts.


[1] [1] Mannelli et al. Osteoporos. Int. 26, s.1 (2015).